Psychosocial Screening for Cancer Patients: Turkish Validity and Reliability Study of the Basic Documentation for Psycho-oncology (PO-BADO)


Baghirova Nas U., Keskin M., ANUK D., ÖZKAN M., POLAT I.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, cilt.40, sa.4, ss.310-317, 2025 (ESCI, Scopus, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 4
  • Basım Tarihi: 2025
  • Doi Numarası: 10.5505/tjo.2025.4739
  • Dergi Adı: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.310-317
  • İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVE Cancer is a systemic disease caused by many different factors that negatively affect people's lives and may substantially reduce the quality of life. The Basic Documentation for Psycho-Oncology (PO-BADO) is an expert rating scale for assessing distress in cancer patients. The main aim of this study is to evaluate the validity and reliability of this scale in Turkish. METHODS 151 patients with oncologic diagnoses were included in the study. Sociodemographic Data Form, The Basic Documentation For Psycho-Oncology (PO-BADO), Hospital Anxiety and Depression Scale (HADS), Perceived Stress Scale (PSS), Karnofsky Performance Scale (KPS), and Cancer Coping Questionnaire (CCQ) were conducted. RESULTS The PO-BADO scale demonstrated a high level of internal consistency, with Cronbach's alpha of 0.826 for the overall scale, 0.792 for the physical symptoms subscale, and 0.749 for the mental symptoms sub-scale. PO-BADO scores showed strong positive correlation with HADS and PSS scores (r=0.657, 0.769, 0.763 and 0.685), and moderate negative correlation (r=-0.527) with KPS scores. Confirmatory factor analysis yielded an x2/sd value lower than 3, a CFI of 0.97, and an RMSEA of 0.034. CONCLUSION Our results indicate that the Turkish version of PO-BADO is a valid tool for evaluating mental health issues, as well as the medical challenges experienced by Turkish cancer patients.